It is a link for moving within the page.

Go to the main.
Go to the global navigation.
Go to navigation by category.
Go to the footer.

News Releases

RSS

29 JUL 2020Pharmaceuticals: Otsuka Filed Application in Japan for Approval of Fremanezumab as a Prophylactic Treatment for Migraine

8 JUL 2020Pharmaceuticals: Otsuka announces simultaneous regulatory approvals by U.S. FDA and Health Canada of INQOVI^®, an oral hypomethylating agent (HMA) therapy for MDS and CMML

29 JUN 2020Pharmaceuticals: Novartis Pharma obtains manufacturing and marketing approval in Japan for Entresto^® tablet as angiotensin receptor neprilysin inhibitor (ARNI) for chronic heart failure

29 JUN 2020Pharmaceuticals: Samsca^®approved in Japan for additional indication of hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion (SIADH)

29 JUN 2020Pharmaceuticals: Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications

24 JUN 2020Pharmaceuticals: Clinical program for NY-ESO-1/siTCR^TM gene therapy candidate receives designation in Japan as Orphan Regenerative Medicine

19 JUN 2020Pharmaceuticals: Japan's MHLW grants Sakigake Designation to comprehensive genomic profiling assay for hematologic malignancies co-developed by Otsuka

16 JUN 2020Nutraceuticals: Introduction of Set of Heat Disorder-related Teaching Materials: "Get Back That Sweat! Preventing Heat Disorders Together"

16 JUN 2020Pharmaceuticals: Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, AILAMIDE^® Combination Ophthalmic Suspension

12 JUN 2020Pharmaceuticals: Otsuka Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients

RSS